Alpha Tau Medical Ltd. (DRTS) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Jerusalem, 以色列. 现任CEO为 Uzi Sofer.
DRTS 拥有 IPO日期为 2021-03-08, 125 名全职员工, 在 NASDAQ Capital Marke, 市值为 $689.12M.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
